Neurocrine Biosciences Inc
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/3/2026 | 1,443 | 0.0% | 10,171 | 12/31/2025 |
| 2025 Q3 | 10/24/2025 | 1,446 | 0.0% | 10,300 | 9/30/2025 |
| 2025 Q2 | 7/10/2025 | 1,372 | 0.0% | 10,916 | 6/30/2025 |
| 2025 Q1 | 4/28/2025 | 1,235 | 0.0% | 11,168 | 3/31/2025 |
| 2024 Q4 | 1/28/2025 | 1,531 | 0.0% | 11,218 | 12/31/2024 |
| 2024 Q3 | 10/17/2024 | 1,293 | 0.0% | 11,218 | 9/30/2024 |
| 2024 Q2 | 7/30/2024 | 1,574 | 0.0% | 11,436 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 1,565 | 0.0% | 11,346 | 3/31/2024 |
| 2023 Q4 | 2/1/2024 | 1,185 | 0.0% | 8,997 | 12/31/2023 |
| 2023 Q3 | 10/30/2023 | 942 | 0.0% | 8,369 | 9/30/2023 |
| 2023 Q2 | 8/4/2023 | 791 | 0.0% | 8,390 | 6/30/2023 |
| 2023 Q1 | 5/2/2023 | 828 | 0.0% | 8,176 | 3/31/2023 |
| 2022 Q4 | 1/26/2023 | 977 | 0.0% | 8,176 | 12/31/2022 |
| 2022 Q3 | 10/19/2022 | 863 | 0.0% | 8,130 | 9/30/2022 |
| 2022 Q2 | 7/13/2022 | 787 | 0.0% | 8,069 | 6/30/2022 |
| 2022 Q1 | 4/19/2022 | 555 | 0.0% | 5,919 | 3/31/2022 |
| 2021 Q4 | 1/20/2022 | 510 | 0.0% | 5,992 | 12/31/2021 |
| 2021 Q3 | 10/15/2021 | 433 | 0.0% | 4,520 | 9/30/2021 |
| 2021 Q2 | 7/19/2021 | 443 | 0.0% | 4,561 | 6/30/2021 |
| 2021 Q1 | 5/7/2021 | 443 | 0.0% | 4,561 | 3/31/2021 |
| 2020 Q4 | 2/2/2021 | 437 | 0.0% | 4,561 | 12/31/2020 |
| 2020 Q3 | 10/29/2020 | 438 | 0.0% | 4,561 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 554 | 0.0% | 4,546 | 6/30/2020 |
| 2020 Q1 | 4/21/2020 | 393 | 0.0% | 4,546 | 3/31/2020 |
| 2019 Q4 | 1/24/2020 | 580 | 0.0% | 5,396 | 12/31/2019 |